Issues‎ > ‎vol7no2‎ > ‎


High Sensitivity C-Reactive Protein and Cholesterol Level as Risk Markers for Both Periodontitis and Coronary Artery Disease

Balen J. Hama* , Faraedon M. Zardawi**, Hemn M. Mustafa*** , Sarhang S. Gul**
 * Kurdistan Board for Medical Specialities, Faculties of Dental Specialities, Restorative Dentistry, Sulaimani, Iraq. 
 **Periodontics Department, College of Dentistry, University of Sulaimani, Sulaimani.Iraq. 
 ***Department of Medicine, College of Medicine, University of Sulaimani, Sulaimani, Iraq.
Submitted: September 30, 2020, Accepted: November 11, 2020, Published: June 1, 2021.


ObjectivesThe association between periodontal disease and cardiovascular disease (CVD) has received considerable attention, although it is unclear whether there is a causal component. Therefore, this study aimed to determine the Correlation between high sensitivity C reactive protein (hs-CRP) and total blood cholesterol levels in periodontitis (PD) and coronary artery disease (CAD).          

MethodsEighty subjects (40 males and 40 females) divided into four equal groups: Group 1: control group, healthy without CAD or PD, group 2: PD without CAD (n=20). group 3: PD with CAD, and group 4: CAD without PD. Periodontitis was defined according to the 2017 periodontal disease classification. Periodontal probing depth (PPD) and clinical attachment level (CAL) were recorded. All participants were assessed for CAD by angiography (coronary computed tomography angiography or coronary angiography). Finally, serum hs-CRP and total cholesterol levels were determined by using the particle enhanced immunoturbidimetric assay method.      

Results: The median of serum cholesterol and hs-CRP levels was significantly lower in the control group than the patients’ groups (P<0.05). There were no statistically significant differences in gender and age among the studied groups (P>0.05). Furthermore, significant, positive, and strong correlations of PPD and CAL with the hs-CRP and Cholesterol.  

ConclusionsSerum levels of hs-CRP and Cholesterol were positively proportionate to the measurements of CAL and PPD by increasing the severity of PD parameters (PPD and CAL), serum level of CAD biomarkers (hs-CRP and Cholesterol) were increased.

Keywords: Periodontitis, Coronary artery disease, Hs-CRP, Cholesterol.                                                                                                                                                                                            Full Article - PDF 



1. Valensia R, Sri Lelyati C, Masulili LC, Lessang R, Radi B. Association between blood cholesterol level with periodontal status of coronary heart disease patients. AIP Conference Proceedings 2017.
2. Roth GA, Johnson C, Abajobir A. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1-25.
3. Cekici A, Kantarci A, Hasturk H, Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol2000. 2014;64(1):57-80.
4. Albandar JM, Brunelle JA, Kingman A. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994. J Periodontol. 1999;70(1):13–29.
5. Iacopino AM, Cutler CW. Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids. J Periodontol. 2000;71(8):1375-1384.
6. Schenkein HA, Loos BG. Infammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Clin Periodontol. 2013;40:51S–69S. 
7. Albandar JM. Global risk factors and risk indicators for periodontal diseases. Periodontol 2000. 2001;29(1):177–206.
8. Moore WE, Moore LV. The bacteria of periodontal diseases. Periodontol 2000. 1994;5:66-77.
9. Al-Zahrani MS, Kayal RA, Bissada NF. Periodontitis and cardiovascular disease: a review of shared risk factors and new findings supporting a causality hypothesis. Quintessence Int. 2006;37(1):11-18.
10. Beck JD, Offenbacher S. Relationships among clinical measures of periodontal disease and their associations with systemic markers. Ann Periodontol. 2002;7(1):79-89.
11. Kim J, Amar S. Periodontal disease and systemic conditions: a bidirectional relationship. Odontology. 2006;94(1):10-21.
12. Gulhar R, Ashraf MA, Jialal I. Physiology, acute phase reactants. StatPearls.
13. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336(14):973-979.
14. Husain TM, Kim DH, C-reactive protein and erythrocyte sedimentation rate in orthopaedics. Univ Pennsylvania Orthop J. 2002;15:13-16
15. You Z, Cushman M, Jenny NS, Howard G;. Tooth loss, systemic inflammation, and prevalent stroke among participants in the reasons for geographic and racial difference in stroke study. Atherosclerosis. 2009;203(2):615-619.
16. Meisel P, Kohlmann T, Wallaschofski H, Kroemer HK, Kocher T. Cholesterol, C-Reactive Protein, and Periodontitis: HMG-CoA-Reductase Inhibitors (Statins) as Effect Modifiers. ISRN Dentistry. 2011;2011:125168.
17. Ramamoorthy RD, Nallasamy V, Reddy R, Esther N, Maruthappan Y. A review of C-reactive protein: A diagnostic indicator in periodontal medicine. J Pharm Bioallied Sci. 2012;4(Suppl 2):S422-S26.
18. Pattnaik NK, Das SN, Biswal BN. Cardiovascular diseases and periodontal piseases: Review and update. Int. J Sci Study. 2017;5(1):239-44.
19. Kholy KE, Genco RJ, Van Dyke TE. Oral infections and cardiovascular disease. Trends Endocrinol Metab. 2015;26(6):315-321.
20. Lockhart PB, Bolger AF, Papapanou PN. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation. 2012;125(20):2520-44.
21. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129 (25 Suppl 2):S49-S73. 
22. Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri‐Implant Diseases and Conditions. Journal of periodontology. 2018;89:S173-S82.
23. Jaramillo A, Lafaurie GI, Millán LV. Association between periodontal disease and plasma levels of Cholesterol and triglycerides. Colomb Med (Cali). 2013;44(2):80-86.
24. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res. 2000;79(1):49-57.
25. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal Infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001;72:1221–1227. 
26. Katz J, Flugelman MY, Goldberg A, Heft M. Association between periodontal pockets and elevated Cholesterol and low density lipoprotein cholesterol levels. J Periodontol. 2002;73(5):494- 500.
27. Craig RG, Yip JK, So MK, Boylan RJ, Socransky SS, Haffajee AD. Relationship of destructive periodontal disease to the acute-phase response. J Periodontol. 2003;74(7):1007-1016.
28. Kumar KR, Ranganath V, Naik R, Banu S, Nichani AS. Assessment of high-sensitivity C- reactive protein and lipid levels in healthy adults and patients with coronary artery disease, with and without periodontitis--a cross-sectional study. J Periodontal Res. 2014;49(6):836-844.
29. Schenkein HA, Papapanou PN, Genco R, Sanz M. Mechanisms underlying the association between periodontitis and atherosclerotic disease. Periodontology 2000. 2020;83(1):90-106.
30. Meisel P, Kohlmann T, Wallaschofski H, Kroemer HK, Kocher T. Cholesterol, C-Reactive protein, and Periodontitis: HMG -CoA-Reductase Inhibitors (Statins) as Effect Modifiers. ISRN Dent. 2011;2011:125168.
31. Meisel P, Kroemer HK, Nauck M, Holtfreter B, Kocher T. Tooth loss, periodontitis, and statins in a population‐based follow‐up study. J Periodontol. 2014; 85(6): e160‐ e168.
32. Shivakumar TP, Patil VA, Desai MH. Periodontal status in subjects with hyperlipidemia and determination of association between hyperlipidemia and periodontal health: A Clinicobiochemical Study. J Contemp Dent Pract. 2013;14(5):785-789. 
33. Sen S, Giamberardino LD, Moss K. Periodontal Disease, Regular Dental Care Use, and Incident Ischemic Stroke. Stroke. 2018;49(2):355-62.
34. Goulart AC, Armani F, Arap AM, Nejm T, Andrade JB, Bufarah HB, et al. Relationship between periodontal disease and cardiovascular risk factors among young and middle-aged Brazilians. Cross-sectional study. Sao Paulo Med J. 2017;135(3):226-33.
35. Beukers NG, van der Heijden GJ, van Wijk AJ, Loos BG. Periodontitis is an independent risk indicator for atherosclerotic cardiovascular diseases among 60 174 participants in a large dental school in the Netherlands. J Epidemiol Community Health. 2017;71(1):37-42.
36. Gersh B. Age-Dependent Associations Between Chronic Periodontitis/Edentulism and Risk of Coronary Heart Disease Dietrich T, Jimenez M, Kaye EAK, et al (Boston Univ Goldman School of Dental Med, MA; et al) Circulation 117: 1668- 1674, 2008. Year Book of Cardiology. 2009;2009:321-3.
37. Desvarieux Ms, Schwahn C, Volzke H, Demmer RT, Ludemann J, Kessler C, et al. Gender differences in the relationship between periodontal disease, tooth loss, and atherosclerosis. Stroke. 2004;35(9):2029-35.
38. Ebersole J, Machen R, Steffen M, Willmann D. Systemic acute‐phase reactants, C‐reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol. 1997;107(2):347-52.
39. Herrera D, Molina A, Buhlin K, Klinge B. Periodontal diseases and association with atherosclerotic disease. Periodontol 2000. 2020;83(1):66-89.
40. Zardawi F, Gul S, Abdulkareem A, Sha A and Yates J. Association Between Periodontal Disease and Atherosclerotic Cardiovascular Diseases: Revisited. Front. Cardiovasc. Med. 2021;7:625579.

Creative Commons License © The Authors, published by University of Sulaimani, College of Dentistry